Lataa...
Statins improve survival in patients previously treated with nivolumab for advanced non-small cell lung cancer: An observational study
There are a number of suggested predictive factors of nivolumab for non-small cell lung cancer (NSCLC), however, there is not enough evidence to determine a single factor that can predict the efficacy of nivolumab. As the progress of biomarkers for cancer treatment is improving, it has been speculat...
Tallennettuna:
| Julkaisussa: | Mol Clin Oncol |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
D.A. Spandidos
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6313973/ https://ncbi.nlm.nih.gov/pubmed/30655989 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2018.1765 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|